Education
About Us
Working with TipRanks
Follow Us
Lumos Pharma, Inc. (LUMO)
:LUMO
LUMO Stock Chart & Stats
Day’s RangeN/A
52-Week Range― - ―
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Lumos Pharma News
PremiumCompany Announcements
Lumos Pharma Completes Merger and Delisting Process
PremiumCompany Announcements
Lumos Pharma Faces Uncertainty as CVRs Risk Expiring Worthless Post-Merger
Options Prices
Currently, No data available
---
Ownership Overview
― Insiders
0.71% Mutual Funds
― Other Institutional Investors
99.29% Public Companies and
Individual Investors
LUMO FAQ
What was Lumos Pharma, Inc.’s price range in the past 12 months?
Currently, no data Available
What is Lumos Pharma, Inc.’s market cap?
Currently, no data Available
When is Lumos Pharma, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Lumos Pharma, Inc.’s earnings last quarter?
Currently, no data Available
Is Lumos Pharma, Inc. overvalued?
According to Wall Street analysts Lumos Pharma, Inc.’s price is currently Undervalued.
Does Lumos Pharma, Inc. pay dividends?
Lumos Pharma, Inc. does not currently pay dividends.
What is Lumos Pharma, Inc.’s EPS estimate?
Lumos Pharma, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lumos Pharma, Inc. have?
Currently, no data Available
What happened to Lumos Pharma, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Lumos Pharma, Inc.?
Currently, no hedge funds are holding shares in LUMO
Company Description
Lumos Pharma, Inc.
Lumos Pharma, Inc. (LUMO) is a clinical-stage biopharmaceutical company focused on the development of therapeutics for rare and neglected diseases. The company is committed to advancing its pipeline of products, primarily targeting diseases with significant unmet medical need. Lumos Pharma's lead product candidate is LUM-201, an investigational oral growth hormone secretagogue, being developed for the treatment of pediatric growth hormone deficiency (PGHD) and other growth disorders.
Xoma
―
Heron Therapeutics
―
ESSA Pharma
―
Bioxcel Therapeutics
―
PAVmed
―
Crinetics Pharmaceuticals
―